id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-271930-9a18h2tr	Licari, Amelia	Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares	2020-05-28		.txt	text/plain	1177	83	47	The Center for Disease Control and Prevention (CDC) initially proposed that patients with chronic lung diseases, including moderate-severe asthma, and allergy may have a higher risk of developing severe COVID-19 than otherwise healthy people (https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/asthma.html). Allergic children had a significantly higher (P < .0001) eosinophil count than COVID-19 patients. However, it has been recently commented that chronic respiratory diseases, including COPD and asthma, seem to be underrepresented in the comorbidities of COVID-19 patients. On the other hand, children and adolescents with allergy and asthma should be adequately managed during this COVID-19 pandemic, also considering the restrictive rules released by governmental authorities that impose a strict limitation on movements. 10 In summary, the rapid spread of SARS-CoV-2 infection and the lack of specific antiviral therapies and vaccines currently require additional medical efforts to prevent COVID-19 and mostly protect patients with chronic diseases. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor, ACE2 Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?	./cache/cord-271930-9a18h2tr.txt	./txt/cord-271930-9a18h2tr.txt